Volume 26, Number 3—March 2020
CME ACTIVITY - Synopsis
Clinical Characteristics of Disseminated Strongyloidiasis, Japan, 1975–2017
Table 2
Characteristic | No. patients |
|||||||
---|---|---|---|---|---|---|---|---|
All patients |
Dissemination |
Occult dissemination with meningitis/enteric organisms |
Occult dissemination with culture-negative suppurative meningitis |
|||||
No. patients |
70 (100) |
32 (45.7) |
12 (17.1) |
26 (37.1) |
||||
Symptoms* | ||||||||
Fever | 37 (52.9) | 15 (46.9) | 8 (66.7) | 14 (53.8) | ||||
Headache | 23 (32.9) | 3 (9.4) | 7 (58.3) | 13 (50.0) | ||||
Altered mental status | 17 (24.3) | 7 (21.9) | 3 (25.0) | 7 (26.9) | ||||
Nausea or vomiting | 10 (14.3) | 4 (12.5) | 1 (8.3) | 5 (19.2) | ||||
Abdominal pain | 6 (8.6) | 2 (6.3) | 2 (16.7) | 2 (7.7) | ||||
Anorexia | 5 (7.1) | 4 (12.5) | 1 (8.3) | 0 (0) | ||||
Constipation | 1 (1.4) | 0 (0) | 1 (8.3) | 0 (0) | ||||
Diarrhea |
1 (1.4) |
0 (0) |
0 (0) |
1 (3.8) |
||||
Clinical diagnosis† | ||||||||
Full-blown dissemination‡ | 9 (12.9) | 9 (28.1) | 0 (0) | 0 (0) | ||||
Sepsis | 23 (32.9) | 13 (40.6) | 7 (58.3) | 3 (11.5) | ||||
Meningitis (enteric) | 22 (31.4) | 10 (31.3) | 12 (100) | 0 (0) | ||||
Meningitis (culture-negative) | 34 (48.6) | 8 (25) | 0 (0) | 26 (100) | ||||
Pneumonia | 27 (38.6) | 26 (81.3) | 0 (0) | 1 (3.8) | ||||
Paralytic ileus | 17 (24.3) |
15 (46.9) |
1 (8.3) |
1 (3.8) |
*Other symptoms that were only noted in patients with dissemination included cough (2 cases), and rash, fatigue, convulsion, and syncope (1 case each).
†Other diagnoses that were only identified in patients with dissemination included peritonitis (6 cases), dermatitis (5 cases), and esophagitis (1 case).
‡Full-blown dissemination is the severest form of dissemination and hyperinfection, referring to patients with paralytic ileus and pneumonia caused by enteric organisms, as well as either sepsis or meningitis caused by enteric organisms.
Page created: February 19, 2020
Page updated: February 19, 2020
Page reviewed: February 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.